Hyperfine, Inc. (HYPR)
NASDAQ: HYPR · Real-Time Price · USD
1.150
-0.010 (-0.86%)
At close: Feb 20, 2026, 4:00 PM EST
1.140
-0.010 (-0.87%)
After-hours: Feb 20, 2026, 4:54 PM EST
Hyperfine Market Cap
Hyperfine has a market cap or net worth of $111.74 million as of February 20, 2026. Its market cap has decreased by -5.44% in one year.
Market Cap
111.74M
Enterprise Value
90.36M
1-Year Change
-5.44%
Ranking
Category
Stock Price
$1.15
Market Cap Chart
Since January 27, 2021, Hyperfine's market cap has increased from $45.05M to $111.74M, an increase of 148.07%. That is a compound annual growth rate of 19.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 111.74M | 17.43% |
| Dec 31, 2025 | 95.16M | 48.23% |
| Dec 31, 2024 | 64.19M | -19.95% |
| Dec 29, 2023 | 80.19M | 35.27% |
| Dec 30, 2022 | 59.28M | -88.32% |
| Dec 31, 2021 | 507.73M | 1,027.17% |
| Jan 27, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CVRx, Inc. | 150.50M |
| Apyx Medical | 149.76M |
| AVITA Medical | 143.66M |
| LENSAR | 137.42M |
| Treace Medical Concepts | 121.70M |
| Sera Prognostics | 100.54M |
| Picard Medical | 92.13M |
| Neuronetics | 89.72M |